Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer Center.

Indian J Med Paediatr Oncol · 2017 · PMC5686973 · PMID 29200680

Europe PMC DOI

hedged sentence

0.1250

closest p · 2.5× alpha

0.1250

boldest claim

The sentences

did not reach statistical significanceP = 0.125not close (p > 0.1)

Patients exposed to the second line of therapy (25%), predominantly everolimus in our study, seemed to do better than those who were unable to receive the same and this approached but did not reach statistical significance ( P = 0.125).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.